HealtheRx Survey for Pulmonary Research Registry Recruitment
1 other identifier
interventional
41
1 country
1
Brief Summary
The purpose of this research is to study the utility of using the HealtheRx as a tool to recruit eligible patients into the Pulmonary Research Registry (PRR) (IRB 15543B) at the University of Chicago. HealtheRx is an example of a potential recruitment tool that has high reach in populations typically underrepresented in research studies, uses a high tech infrastructure that allows matching of research opportunities to patient characteristics, but that delivers information in a low-tech, patient-centered mode using the printed HealtheRx prescription.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable asthma
Started Dec 2015
Longer than P75 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 8, 2016
CompletedFirst Posted
Study publicly available on registry
January 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedApril 29, 2020
April 1, 2020
1.4 years
January 8, 2016
April 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cost per consented subject
6 months
Secondary Outcomes (1)
Mean number of consented subjects per week
6 months
Other Outcomes (2)
Proportion of individuals who consent
6 months
Mean days to consent
6 months
Study Arms (3)
Control
NO INTERVENTIONParticipant is recruited via usual avenues including flyers and physician referral. This includes participants who received a HealtheRx with advertisement for phone survey but did not call in based on advertisement.
Intervention with consent form
EXPERIMENTALAfter completing survey, participant in HealtheRx+ group receives $5 bill with their survey check and blank registry consent form.
Intervention with return of consent form
EXPERIMENTALAfter returning signed consent form, participant in HealtheRx++ group is mailed $5 bill.
Interventions
Participant receives $5 bill when they returned signed PRR consent form.
Eligibility Criteria
You may qualify if:
- diagnosis of asthma/COPD
- receipt of HealtheRx
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Chicago
Chicago, Illinois, 60637, United States
Related Publications (1)
Feldmeth G, Naureckas ET, Solway J, Lindau ST. Embedding research recruitment in a community resource e-prescribing system: lessons from an implementation study on Chicago's South Side. J Am Med Inform Assoc. 2019 Aug 1;26(8-9):840-846. doi: 10.1093/jamia/ocz059.
PMID: 31181137DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stacy Lindau, MD
University of Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2016
First Posted
January 12, 2016
Study Start
December 1, 2015
Primary Completion
April 25, 2017
Study Completion
December 1, 2019
Last Updated
April 29, 2020
Record last verified: 2020-04